Annual Cash & Cash Equivalents
$133.32 M
-$253.22 M-65.51%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual cash & cash equivalents is $133.32 million, with the most recent change of -$253.22 million (-65.51%) on December 31, 2023.
- During the last 3 years, ABCL annual cash & cash equivalents has fallen by -$460.80 million (-77.56%).
- ABCL annual cash & cash equivalents is now -77.56% below its all-time high of $594.12 million, reached on December 31, 2020.
Performance
ABCL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$126.64 M
-$21.67 M-14.61%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly cash and cash equivalents is $126.64 million, with the most recent change of -$21.67 million (-14.61%) on September 30, 2024.
- Over the past year, ABCL quarterly cash and cash equivalents has dropped by -$21.67 million (-14.61%).
- ABCL quarterly cash and cash equivalents is now -84.02% below its all-time high of $792.57 million, reached on June 30, 2021.
Performance
ABCL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ABCL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.5% | -14.6% |
| 3 y3 years | -77.6% | -75.5% |
| 5 y5 years | +1176.5% | +1576.7% |
ABCL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.0% | at low | -84.0% | +2.5% |
| 5 y | 5-year | -77.6% | +1665.1% | -84.0% | +1576.7% |
| alltime | all time | -77.6% | +1665.1% | -84.0% | +1576.7% |
AbCellera Biologics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $126.64 M(-14.6%) |
| Jun 2024 | - | $148.31 M(+20.0%) |
| Mar 2024 | - | $123.57 M(-7.3%) |
| Dec 2023 | $133.32 M(-65.5%) | $133.32 M(-22.7%) |
| Sep 2023 | - | $172.42 M(-4.1%) |
| Jun 2023 | - | $179.75 M(-6.9%) |
| Mar 2023 | - | $193.02 M(-50.1%) |
| Dec 2022 | $386.54 M | $386.54 M(+3.9%) |
| Sep 2022 | - | $371.97 M(-53.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $790.62 M(+44.9%) |
| Mar 2022 | - | $545.72 M(+14.6%) |
| Dec 2021 | $476.14 M(-19.9%) | $476.14 M(-8.0%) |
| Sep 2021 | - | $517.69 M(-34.7%) |
| Jun 2021 | - | $792.57 M(+15.6%) |
| Mar 2021 | - | $685.79 M(+15.4%) |
| Dec 2020 | $594.12 M(+7766.0%) | $594.12 M(+552.3%) |
| Sep 2020 | - | $91.08 M(+1105.9%) |
| Dec 2019 | $7.55 M(-27.7%) | $7.55 M |
| Dec 2018 | $10.44 M | - |
FAQ
- What is AbCellera Biologics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AbCellera Biologics?
- What is AbCellera Biologics annual cash & cash equivalents year-on-year change?
- What is AbCellera Biologics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AbCellera Biologics?
- What is AbCellera Biologics quarterly cash and cash equivalents year-on-year change?
What is AbCellera Biologics annual cash & cash equivalents?
The current annual cash & cash equivalents of ABCL is $133.32 M
What is the all time high annual cash & cash equivalents for AbCellera Biologics?
AbCellera Biologics all-time high annual cash & cash equivalents is $594.12 M
What is AbCellera Biologics annual cash & cash equivalents year-on-year change?
Over the past year, ABCL annual cash & cash equivalents has changed by -$253.22 M (-65.51%)
What is AbCellera Biologics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ABCL is $126.64 M
What is the all time high quarterly cash and cash equivalents for AbCellera Biologics?
AbCellera Biologics all-time high quarterly cash and cash equivalents is $792.57 M
What is AbCellera Biologics quarterly cash and cash equivalents year-on-year change?
Over the past year, ABCL quarterly cash and cash equivalents has changed by -$21.67 M (-14.61%)